GATA-1	B-protein
DNA	O
binding	O
activity	O
is	O
down-regulated	O
in	O
late	O
S	O
phase	O
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

We	O
have	O
set	O
out	O
to	O
test	O
a	O
model	O
for	O
tissue-specific	O
gene	O
expression	O
that	O
relies	O
on	O
the	O
early	O
replication	O
of	O
expressed	O
genes	O
to	O
sequester	O
limiting	O
activating	O
transcription	B-protein
factors	I-protein
.	O

Using	O
an	O
erythroid	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
we	O
have	O
tested	O
the	O
changes	O
in	O
the	O
DNA	O
binding	O
activity	O
of	O
the	O
lineage-restricted	B-protein
transcription	I-protein
factor	I-protein
GATA-1	B-protein
through	O
the	O
cell	O
cycle	O
.	O

We	O
find	O
that	O
GATA-1	B-protein
activity	O
is	O
low	O
in	O
G1	O
,	O
peaks	O
in	O
mid-S	O
phase	O
,	O
and	O
then	O
decreases	O
in	O
G2/M	O
.	O

In	O
contrast	O
,	O
the	O
binding	O
activities	O
of	O
two	O
ubiquitous	O
transcription	B-protein
factors	I-protein
,	O
Oct1	B-protein
and	O
Sp1	B-protein
,	O
remain	O
high	O
in	O
G2/M	O
.	O

GATA-1	B-protein
protein	O
and	O
mRNA	B-RNA
vary	O
in	O
a	O
similar	O
manner	O
through	O
the	O
cell	O
cycle	O
,	O
suggesting	O
that	O
the	O
expression	O
of	O
the	O
gene	O
or	O
the	O
stability	O
of	O
its	O
message	O
is	O
regulated	O
.	O

Although	O
a	O
number	O
of	O
transcription	B-protein
factors	I-protein
involved	O
in	O
the	O
control	O
of	O
the	O
cell	O
cycle	O
or	O
DNA	O
replication	O
have	O
been	O
shown	O
to	O
peak	O
in	O
S	O
phase	O
,	O
this	O
is	O
the	O
first	O
example	O
of	O
a	O
lineage-restricted	B-protein
transcription	I-protein
factor	I-protein
displaying	O
S	O
phase-specific	O
DNA	O
binding	O
activity	O
.	O

One	O
interpretation	O
of	O
these	O
data	O
leads	O
to	O
a	O
model	O
in	O
which	O
the	O
peak	O
in	O
GATA-1	B-protein
DNA	O
binding	O
amplifies	O
the	O
effect	O
of	O
early	O
replication	O
on	O
the	O
activation	O
of	O
erythroid-specific	B-DNA
genes	I-DNA
at	O
the	O
same	O
time	O
as	O
preventing	O
activation	O
of	O
non-erythroid	B-DNA
genes	I-DNA
containing	O
GATA-responsive	B-DNA
elements	I-DNA
.	O

These	O
results	O
may	O
also	O
relate	O
to	O
recent	O
data	O
implicating	O
GATA-1	B-protein
function	O
in	O
apoptosis	O
and	O
cell	O
cycle	O
progression	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

4	NULL
,	NULL
Issue	NULL
of	NULL
January	NULL
24	NULL
,	NULL
pp	NULL
.	NULL

2464-2469	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Activity	NULL
Is	NULL
Down-regulated	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
in	NULL
Erythroid	NULL
Cells*	NULL
Martin	NULL
E.	NULL
Cullen	NULL
}	NULL
and	NULL
Roger	NULL
K.	NULL
Patient§	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
28	NULL
,	NULL
1996	NULL
)	NULL
From	NULL
the	NULL
Developmental	NULL
Biology	NULL
Research	NULL
Centre	NULL
,	NULL
The	NULL
Randall	NULL
Institute	NULL
,	NULL
King	NULL
's	NULL
College	NULL
London	NULL
,	NULL
26-29	NULL
Drury	NULL
Lane	NULL
,	NULL
London	NULL
WC2B	NULL
SRL	NULL
,	NULL
United	NULL
Kingdom	NULL
We	NULL
have	NULL
set	NULL
out	NULL
to	NULL
test	NULL
a	NULL
model	NULL
for	NULL
tissue-specific	NULL
gene	NULL
expression	NULL
that	NULL
relies	NULL
on	NULL
the	NULL
early	NULL
replication	NULL
of	NULL
expressed	NULL
genes	NULL
to	NULL
sequester	NULL
limiting	NULL
activating	NULL
transcription	NULL
factors	NULL
.	NULL

Using	NULL
an	NULL
erythroid	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
have	NULL
tested	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

We	NULL
find	NULL
that	NULL
GATA-1	NULL
activity	NULL
is	NULL
low	NULL
in	NULL
G	NULL
,	NULL
,	NULL
peaks	NULL
in	NULL
mid-S	NULL
phase	NULL
,	NULL
and	NULL
then	NULL
decreases	NULL
in	NULL
Gy/M	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
two	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
,	NULL
Octl	NULL
and	NULL
Spl	NULL
,	NULL
remain	NULL
high	NULL
in	NULL
GATA-1	NULL
protein	NULL
and	NULL
mRNA	NULL
vary	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
or	NULL
the	NULL
stability	NULL
of	NULL
its	NULL
message	NULL
is	NULL
regulated	NULL
.	NULL

Although	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
or	NULL
DNA	NULL
replication	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
peak	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
example	NULL
of	NULL
a	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
displaying	NULL
S	NULL
phase-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
these	NULL
data	NULL
leads	NULL
to	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
peak	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
amplifies	NULL
the	NULL
effect	NULL
of	NULL
early	NULL
replication	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
at	NULL
the	NULL
same	NULL
time	NULL
as	NULL
preventing	NULL
activation	NULL
of	NULL
non-erythroid	NULL
genes	NULL
containing	NULL
GATA-responsive	NULL
elements	NULL
.	NULL

These	NULL
results	NULL
may	NULL
also	NULL
relate	NULL
to	NULL
recent	NULL
data	NULL
implicating	NULL
GATA-1	NULL
function	NULL
in	NULL
apoptosis	NULL
and	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
cell	NULL
division	NULL
and	NULL
differentiation	NULL
is	NULL
still	NULL
unclear	NULL
.	NULL

In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
it	NULL
has	NULL
long	NULL
been	NULL
thought	NULL
that	NULL
differentiation	NULL
requires	NULL
prior	NULL
or	NULL
concomitant	NULL
cell	NULL
division	NULL
(	NULL
1	NULL
)	NULL
,	NULL
but	NULL
direct	NULL
evidence	NULL
for	NULL
a	NULL
mechanistic	NULL
relationship	NULL
has	NULL
been	NULL
hard	NULL
to	NULL
obtain	NULL
.	NULL

One	NULL
potential	NULL
mechanism	NULL
involves	NULL
the	NULL
effect	NULL
of	NULL
DNA	NULL
replication	NULL
on	NULL
repressive	NULL
chromatin	NULL
and	NULL
stable	NULL
transcription	NULL
complexes	NULL
.	NULL

The	NULL
passage	NULL
of	NULL
a	NULL
replication	NULL
fork	NULL
through	NULL
a	NULL
chromatin	NULL
template	NULL
is	NULL
known	NULL
to	NULL
transiently	NULL
disrupt	NULL
both	NULL
histone	NULL
octamers	NULL
and	NULL
complexes	NULL
of	NULL
transacting	NULL
factors	NULL
required	NULL
for	NULL
programming	NULL
gene	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Subse-quently	NULL
,	NULL
as	NULL
nucleosomes	NULL
reform	NULL
behind	NULL
the	NULL
replication	NULL
fork	NULL
,	NULL
transcription	NULL
factors	NULL
have	NULL
a	NULL
window	NULL
of	NULL
opportunity	NULL
to	NULL
bind	NULL
and	NULL
either	NULL
reprogram	NULL
gene	NULL
expression	NULL
or	NULL
reassemble	NULL
committed	NULL
genes	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
DNA	NULL
replication	NULL
in	NULL
gene	NULL
activation	NULL
for	NULL
a	NULL
variety	NULL
of	NULL
viral	NULL
and	NULL
cellular	NULL
genes	NULL
has	NULL
been	NULL
provided	NULL
by	NULL
the	NULL
activating	NULL
effect	NULL
of	NULL
an	NULL
origin	NULL
of	NULL
replication	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
nor	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Institute	NULL
of	NULL
Cancer	NULL
Research	NULL
,	NULL
Chester	NULL
Beatty	NULL
Lab-oratories	NULL
,	NULL
237	NULL
Fulham	NULL
Rd	NULL
.	NULL

,	NULL
London	NULL
SW3	NULL
6JB	NULL
,	NULL
UK	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
44-171-465-5349	NULL
;	NULL
Fax	NULL
:	NULL
44-171-497-9078	NULL
.	NULL

2464	NULL
mal	NULL
cellular	NULL
context	NULL
,	NULL
a	NULL
strong	NULL
correlation	NULL
exists	NULL
between	NULL
the	NULL
replication	NULL
timing	NULL
of	NULL
a	NULL
gene	NULL
and	NULL
its	NULL
state	NULL
of	NULL
transcriptional	NULL
activity	NULL
.	NULL

Specifically	NULL
,	NULL
replication	NULL
early	NULL
in	NULL
S	NULL
phase	NULL
is	NULL
associated	NULL
with	NULL
expression	NULL
for	NULL
a	NULL
large	NULL
number	NULL
of	NULL
tissue-specific	NULL
genes	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
10-13	NULL
)	NULL
.	NULL

A	NULL
well	NULL
studied	NULL
example	NULL
is	NULL
the	NULL
3	NULL
globin	NULL
locus	NULL
,	NULL
which	NULL
is	NULL
replicated	NULL
early	NULL
in	NULL
erythroid	NULL
cells	NULL
where	NULL
it	NULL
is	NULL
transcribed	NULL
but	NULL
late	NULL
in	NULL
fibroblasts	NULL
where	NULL
it	NULL
is	NULL
not	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
major	NULL
determinant	NULL
of	NULL
erythroid	NULL
expression	NULL
of	NULL
this	NULL
locus	NULL
is	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
,	NULL
a	NULL
set	NULL
of	NULL
nuclease	NULL
hypersensitive	NULL
sites	NULL
located	NULL
several	NULL
kilobases	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
gene	NULL
in	NULL
the	NULL
cluster	NULL
.	NULL

The	NULL
locus	NULL
control	NULL
region	NULL
is	NULL
required	NULL
both	NULL
for	NULL
transcription	NULL
and	NULL
early	NULL
replication	NULL
of	NULL
the	NULL
B	NULL
globin	NULL
locus	NULL
(	NULL
15	NULL
)	NULL
,	NULL
further	NULL
maintaining	NULL
the	NULL
correlation	NULL
between	NULL
replication	NULL
timing	NULL
and	NULL
tissue-specific	NULL
gene	NULL
activation	NULL
,	NULL
leading	NULL
to	NULL
a	NULL
model	NULL
where	NULL
early	NULL
replication	NULL
removes	NULL
repressive	NULL
chromatin	NULL
and	NULL
allows	NULL
activating	NULL
transcription	NULL
factors	NULL
to	NULL
bind	NULL
(	NULL
4	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
availability	NULL
is	NULL
clearly	NULL
an	NULL
important	NULL
component	NULL
of	NULL
such	NULL
a	NULL
model	NULL
.	NULL

If	NULL
the	NULL
overall	NULL
nuclear	NULL
concentration	NULL
of	NULL
critical	NULL
factors	NULL
remained	NULL
constant	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
titration	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
early	NULL
replicating	NULL
genes	NULL
would	NULL
limit	NULL
their	NULL
availability	NULL
for	NULL
binding	NULL
to	NULL
later	NULL
replicating	NULL
genes	NULL
with	NULL
the	NULL
same	NULL
control	NULL
sequences	NULL
,	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
for	NULL
the	NULL
early	NULL
replicating	NULL
somatic	NULL
5	NULL
S	NULL
RNA	NULL
genes	NULL
of	NULL
Xenopus	NULL
(	NULL
4	NULL
,	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
sequestration	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
prevent	NULL
activation	NULL
of	NULL
genes	NULL
replicating	NULL
in	NULL
late	NULL
S	NULL
phase	NULL
would	NULL
be	NULL
further	NULL
enhanced	NULL
by	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
factor	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
considerations	NULL
have	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
fluctuations	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
critical	NULL
transacting	NULL
factors	NULL
during	NULL
S	NULL
phase	NULL
may	NULL
amplify	NULL
the	NULL
effect	NULL
on	NULL
chromatin	NULL
remodeling	NULL
conferred	NULL
by	NULL
early	NULL
replication	NULL
(	NULL
6	NULL
)	NULL
.	NULL

We	NULL
have	NULL
set	NULL
out	NULL
to	NULL
test	NULL
this	NULL
model	NULL
,	NULL
using	NULL
an	NULL
erythroid	NULL
cell	NULL
line	NULL
that	NULL
contains	NULL
both	NULL
a	NULL
transcriptionally	NULL
poised	NULL
globin	NULL
gene	NULL
that	NULL
replicates	NULL
during	NULL
the	NULL
first	NULL
half	NULL
of	NULL
S	NULL
phase	NULL
(	NULL
14	NULL
,	NULL
19	NULL
)	NULL
and	NULL
GATA-1	NULL
,	NULL
a	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
crucial	NULL
for	NULL
erythroid	NULL
differentiation	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
that	NULL
has	NULL
potential	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
sequences	NULL
of	NULL
all	NULL
erythroid	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
and	NULL
is	NULL
expressed	NULL
at	NULL
increasingly	NULL
higher	NULL
levels	NULL
during	NULL
erythroid	NULL
maturation	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
find	NULL
that	NULL
the	NULL
availability	NULL
of	NULL
GATA-1	NULL
but	NULL
not	NULL
ubiquitous	NULL
factors	NULL
does	NULL
indeed	NULL
vary	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
a	NULL
manner	NULL
likely	NULL
to	NULL
amplify	NULL
the	NULL
effects	NULL
of	NULL
replication	NULL
timing	NULL
.	NULL

GATA-1	NULL
therefore	NULL
represents	NULL
a	NULL
candidate	NULL
molecule	NULL
for	NULL
linking	NULL
erythroid	NULL
transcription	NULL
and	NULL
early	NULL
replication	NULL
.	NULL

These	NULL
data	NULL
can	NULL
also	NULL
be	NULL
linked	NULL
with	NULL
recent	NULL
observations	NULL
that	NULL
GATA-1	NULL
may	NULL
be	NULL
directly	NULL
involved	NULL
in	NULL
control	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
the	NULL
choice	NULL
among	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
apoptosis	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture	NULL
and	NULL
Cell	NULL
Cycle	NULL
Fractionation-MEL	NULL
'	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
glutamine	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
MEL	NULL
cells	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Decreases	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
calf	NULL
serum	NULL
in	NULL
37	NULL
°C	NULL
incubators	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Asynchronous	NULL
log	NULL
phase	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
different	NULL
stages	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
,	NULL
as	NULL
follows	NULL
.	NULL

10°-10°	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
resuspended	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
approximately	NULL
10	NULL
``	NULL
cells/ml	NULL
,	NULL
and	NULL
injected	NULL
into	NULL
the	NULL
chamber	NULL
of	NULL
a	NULL
Beckman	NULL
JE-5.0	NULL
elutriation	NULL
rotor	NULL
spinning	NULL
at	NULL
3000	NULL
rpm	NULL
containing	NULL
ice-cold	NULL
phosphate-buffered	NULL
saline	NULL
pumped	NULL
at	NULL
21	NULL
ml/min	NULL
.	NULL

The	NULL
pump	NULL
rate	NULL
was	NULL
incremented	NULL
in	NULL
10-15	NULL
steps	NULL
up	NULL
to	NULL
65	NULL
ml/min	NULL
,	NULL
and	NULL
elutriated	NULL
fractions	NULL
were	NULL
collected	NULL
onto	NULL
ice	NULL
.	NULL

Fractions	NULL
were	NULL
then	NULL
pelleted	NULL
,	NULL
resuspended	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Coulter	NULL
counter	NULL
to	NULL
determine	NULL
cell	NULL
concentration	NULL
and	NULL
size	NULL
distribution	NULL
.	NULL

Aliquots	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
removed	NULL
,	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
FACS	NULL
to	NULL
determine	NULL
the	NULL
quality	NULL
of	NULL
the	NULL
elutriation	NULL
.	NULL

Adjacent	NULL
fractions	NULL
that	NULL
consisted	NULL
of	NULL
essentially	NULL
identical	NULL
cell	NULL
cycle	NULL
profiles	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
then	NULL
extracted	NULL
.	NULL

Cell	NULL
Extracts-Elutriated	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
then	NULL
taken	NULL
up	NULL
at	NULL
constant	NULL
cell	NULL
concentration	NULL
in	NULL
ice-cold	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
2	NULL
mM	NULL
MgC	NULL
]	NULL
,	NULL
containing	NULL
0.05	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
a	NULL
mixture	NULL
of	NULL
protease	NULL
(	NULL
5	NULL
mM	NULL
benzamidine	NULL
,	NULL
5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
2	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
2	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
5	NULL
pg/ml	NULL
bestatin	NULL
)	NULL
,	NULL
kinase	NULL
(	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
and	NULL
phosphatase	NULL
(	NULL
1	NULL
M	NULL
B-glycerophosphate	NULL
,	NULL
0.2	NULL
M	NULL
levamisole	NULL
,	NULL
0.25	NULL
M	NULL
NaF	NULL
,	NULL
20	NULL
mM	NULL
sodium	NULL
vanadate	NULL
)	NULL
inhibitors	NULL
.	NULL

After	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
lysed	NULL
cells	NULL
were	NULL
pelleted	NULL
at	NULL
6500	NULL
rpm	NULL
in	NULL
a	NULL
microfuge	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
the	NULL
pelleted	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
2	NULL
volumes	NULL
of	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
containing	NULL
350	NULL
mM	NULL
NaCl	NULL
plus	NULL
inhibitors	NULL
.	NULL

After	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
nuclear	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrif-ugation	NULL
at	NULL
14000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Glycerol	NULL
was	NULL
added	NULL
to	NULL
the	NULL
superna-tants	NULL
to	NULL
25	NULL
%	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
flash	NULL
frozen	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Electophoretic	NULL
Mobility	NULL
Shift	NULL
Assays-Nuclear	NULL
extracts	NULL
(	NULL
0.2-4	NULL
pl	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
7.5	NULL
ul	NULL
of	NULL
4	NULL
X	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
4	NULL
%	NULL
w/v	NULL
Ficoll	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
,	NULL
and	NULL
specific	NULL
competitor	NULL
DNAs	NULL
where	NULL
appropriate	NULL
.	NULL

Specific	NULL
*°P	NULL
end-labeled	NULL
oligonucleotides	NULL
(	NULL
GATA-1	NULL
,	NULL
GCAACTGATA	NULL
AG-GATTC	NULL
(	NULL
29	NULL
)	NULL
;	NULL
Oct1	NULL
,	NULL
AATTCACTGG	NULL
TTCCCAATGA	NULL
TTTGCATGCT	NULL
CT-CACTTCAC	NULL
TG	NULL
;	NULL
Sp1	NULL
,	NULL
GCTAAGGCCC	NULL
CGCCCCCACC	NULL
AAGG	NULL
(	NULL
30	NULL
)	NULL
;	NULL
typically	NULL
20	NULL
fmols	NULL
)	NULL
were	NULL
then	NULL
added	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
30	NULL
pl	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
80	NULL
min	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
non-denaturing	NULL
polyacrylamide/0.5	NULL
X	NULL
TBE	NULL
gel	NULL
that	NULL
had	NULL
been	NULL
pre-electrophoresed	NULL
at	NULL
200	NULL
V	NULL
until	NULL
the	NULL
current	NULL
across	NULL
it	NULL
was	NULL
11	NULL
mA	NULL
.	NULL

After	NULL
2	NULL
h	NULL
electrophoresis	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
gels	NULL
were	NULL
dried	NULL
down	NULL
and	NULL
auto-radiographed	NULL
.	NULL

Laser	NULL
densitometry	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Computing	NULL
Densitometer	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
position	NULL
of	NULL
the	NULL
peak	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
estimated	NULL
by	NULL
using	NULL
the	NULL
quantitative	NULL
FACS	NULL
data	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
,	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

2n	NULL
and	NULL
47	NULL
,	NULL
representing	NULL
DNA	NULL
content	NULL
at	NULL
the	NULL
beginning	NULL
and	NULL
end	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
were	NULL
defined	NULL
as	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
peaks	NULL
in	NULL
fractions	NULL
1	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
n	NULL
value	NULL
for	NULL
the	NULL
fraction	NULL
with	NULL
the	NULL
highest	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
these	NULL
.	NULL

Peak	NULL
values	NULL
from	NULL
four	NULL
separate	NULL
elutriations	NULL
were	NULL
used	NULL
to	NULL
derive	NULL
a	NULL
mean	NULL
cell	NULL
cycle	NULL
position	NULL
for	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Western	NULL
Blotting-Cell	NULL
equivalents	NULL
of	NULL
cell	NULL
cycle-fractionated	NULL
extracts	NULL
were	NULL
separated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
gels	NULL
and	NULL
semi-dry	NULL
electroblotted	NULL
onto	NULL
Hybond	NULL
C+	NULL
nitrocellulose	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

GATA-1	NULL
protein	NULL
was	NULL
im-munodetected	NULL
with	NULL
anti-mouse	NULL
GATA-1	NULL
antibody	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
J.	NULL
D.	NULL
Engel	NULL
)	NULL
after	NULL
blocking	NULL
with	NULL
5	NULL
%	NULL
milk	NULL
powder	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
followed	NULL
by	NULL
binding	NULL
with	NULL
anti-rabbit	NULL
IgG-horseradish	NULL
peroxidase	NULL
and	NULL
treatment	NULL
with	NULL
ECL	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Total	NULL
RNA	NULL
and	NULL
Northern	NULL
Blotting-Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
elutriated	NULL
cells	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
81	NULL
)	NULL
,	NULL
separated	NULL
on	NULL
formaldehyde-agarose	NULL
gels	NULL
,	NULL
alkaline	NULL
blotted	NULL
onto	NULL
Hybond	NULL
N+	NULL
membranes	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
``	NULL
°P	NULL
random	NULL
hexamer-labeled	NULL
GATA-1	NULL
XhoI	NULL
fragment	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
To	NULL
perform	NULL
an	NULL
analysis	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
asynchronous	NULL
MEL	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

This	NULL
technique	NULL
separates	NULL
bulk	NULL
suspension	NULL
cells	NULL
by	NULL
size	NULL
and	NULL
,	NULL
because	NULL
cell	NULL
volume	NULL
increases	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
results	NULL
in	NULL
fractionation	NULL
of	NULL
cells	NULL
according	NULL
to	NULL
their	NULL
position	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
composition	NULL
of	NULL
the	NULL
fractionation	NULL
was	NULL
assessed	NULL
by	NULL
FACS	NULL
analysis	NULL
of	NULL
propidium	NULL
iodide-stained	NULL
cells	NULL
taken	NULL
from	NULL
each	NULL
fraction	NULL
(	NULL
a	NULL
typical	NULL
example	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
for	NULL
a	NULL
typical	NULL
elutriation	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

1b	NULL
(	NULL
cells	NULL
are	NULL
defined	NULL
as	NULL
G	NULL
,	NULL
,	NULL
S	NULL
,	NULL
or	NULL
Gy/M	NULL
depending	NULL
on	NULL
their	NULL
DNA	NULL
2465	NULL
content	NULL
(	NULL
21	NULL
,	NULL
2-4n	NULL
,	NULL
and	NULL
4n	NULL
,	NULL
respectively	NULL
)	NULL
)	NULL
.	NULL

We	NULL
assessed	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Nuclear	NULL
proteins	NULL
,	NULL
salt	NULL
extracted	NULL
from	NULL
equal	NULL
numbers	NULL
of	NULL
cells	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
strong	NULL
GATA-1	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
mouse	NULL
al	NULL
globin	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
and	NULL
electrophoresed	NULL
(	NULL
Fig	NULL
.	NULL

20	NULL
,	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
from	NULL
asynchronous	NULL
MEL	NULL
cells	NULL
was	NULL
also	NULL
analyzed	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
GATA-1	NULL
band	NULL
shift	NULL
was	NULL
confirmed	NULL
by	NULL
comparing	NULL
the	NULL
effects	NULL
of	NULL
specific	NULL
(	NULL
self-competition	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
and	NULL
nonspecific	NULL
(	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
GATA-1	NULL
site	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

Clearly	NULL
,	NULL
there	NULL
is	NULL
variation	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
per	NULL
cell	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
with	NULL
low	NULL
levels	NULL
in	NULL
G	NULL
,	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
,	NULL
an	NULL
increase	NULL
to	NULL
a	NULL
peak	NULL
of	NULL
activity	NULL
in	NULL
S	NULL
phase	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
late	NULL
S/G	NULL
,	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
FACS	NULL
profiles	NULL
for	NULL
these	NULL
fractions	NULL
shows	NULL
that	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
highest	NULL
in	NULL
mid-S	NULL
phase	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
,	NULL
fraction	NULL
5	NULL
)	NULL
compared	NULL
with	NULL
early	NULL
S	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
,	NULL
fraction	NULL
4	NULL
)	NULL
and	NULL
late	NULL
S	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
,	NULL
fraction	NULL
6	NULL
)	NULL
.	NULL

Quantitation	NULL
of	NULL
the	NULL
GATA-1	NULL
band	NULL
intensities	NULL
indicates	NULL
that	NULL
there	NULL
is	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
between	NULL
early	NULL
G	NULL
;	NULL
and	NULL
mid-S	NULL
phase	NULL
and	NULL
an	NULL
11-fold	NULL
decrease	NULL
between	NULL
mid-S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
(	NULL
Fig	NULL
.	NULL

26	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
from	NULL
several	NULL
different	NULL
elutriations	NULL
revealed	NULL
a	NULL
consistent	NULL
peak	NULL
in	NULL
mid-S8	NULL
phase	NULL
.	NULL

The	NULL
position	NULL
of	NULL
this	NULL
peak	NULL
was	NULL
quantitated	NULL
by	NULL
referring	NULL
to	NULL
the	NULL
FACS	NULL
analysis	NULL
of	NULL
each	NULL
elutriation	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
,	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
.	NULL

27	NULL
and	NULL
4n	NULL
,	NULL
representing	NULL
DNA	NULL
content	NULL
at	NULL
the	NULL
beginning	NULL
and	NULL
end	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
were	NULL
defined	NULL
as	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
G	NULL
,	NULL
and	NULL
Gy/M	NULL
peaks	NULL
in	NULL
fractions	NULL
1	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
»	NULL
value	NULL
for	NULL
the	NULL
GATA-1	NULL
binding	NULL
peak	NULL
in	NULL
each	NULL
case	NULL
was	NULL
calculated	NULL
relative	NULL
to	NULL
these	NULL
.	NULL

Data	NULL
from	NULL
four	NULL
separate	NULL
elutriations	NULL
yielded	NULL
a	NULL
mean	NULL
value	NULL
of	NULL
2.981	NULL
with	NULL
a	NULL
standard	NULL
deviation	NULL
of	NULL
0.04	NULL
.	NULL

Thus	NULL
,	NULL
GATA-1	NULL
binding	NULL
activity	NULL
reproducibly	NULL
peaks	NULL
in	NULL
mid-S	NULL
phase	NULL
.	NULL

The	NULL
drop	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
from	NULL
mid-S	NULL
to	NULL
G	NULL
;	NULL
/M	NULL
was	NULL
also	NULL
reproduc-ible	NULL
,	NULL
averaging	NULL
7-fold	NULL
in	NULL
the	NULL
four	NULL
elutriations	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
variation	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
particular	NULL
to	NULL
GATA-1	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
or	NULL
whether	NULL
it	NULL
was	NULL
a	NULL
general	NULL
feature	NULL
shared	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
Oct1	NULL
and	NULL
Spl	NULL
,	NULL
two	NULL
transcription	NULL
factors	NULL
whose	NULL
cell	NULL
cycle-regulated	NULL
DNA	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
characterized	NULL
previously	NULL
.	NULL

Octl	NULL
DNA	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
studied	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
vary	NULL
relative	NULL
to	NULL
bulk	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
except	NULL
during	NULL
mitosis	NULL
,	NULL
when	NULL
it	NULL
loses	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
determined	NULL
Oct1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
equal	NULL
numbers	NULL
of	NULL
MEL	NULL
cells	NULL
by	NULL
EMSA	NULL
,	NULL
using	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
octamer	NULL
motif	NULL
from	NULL
the	NULL
mouse	NULL
IgH	NULL
chain	NULL
gene	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

20	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
result	NULL
seen	NULL
with	NULL
GATA-1	NULL
,	NULL
Octl	NULL
DNA	NULL
binding	NULL
activity	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
peak	NULL
in	NULL
S	NULL
phase	NULL
but	NULL
instead	NULL
is	NULL
highest	NULL
in	NULL
the	NULL
last	NULL
elutriated	NULL
fraction	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mixture	NULL
of	NULL
G	NULL
;	NULL
and	NULL
M	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

20	NULL
,	NULL
middle	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
.	NULL

As	NULL
cell	NULL
volume	NULL
increases	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
nuclear	NULL
concentration	NULL
of	NULL
Octl	NULL
competent	NULL
for	NULL
DNA	NULL
binding	NULL
remains	NULL
broadly	NULL
the	NULL
same	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
published	NULL
data	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

A	NULL
second	NULL
ubiquitous	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
,	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
not	NULL
to	NULL
vary	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
its	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
Spl	NULL
gave	NULL
a	NULL
similar	NULL
result	NULL
to	NULL
Oct1	NULL
,	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
Spl	NULL
DNA	NULL
binding	NULL
activity	NULL
increasing	NULL
progressively	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
Fig	NULL
.	NULL

20	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
two	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factors	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
there	NULL
is	NULL
an	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
concomitant	NULL
with	NULL
increasing	NULL
nuclear	NULL
volume	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
likely	NULL
maintaining	NULL
a	NULL
broadly	NULL
constant	NULL
concentra-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
2466	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Decreases	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
a	NULL
unsynch	NULL
1	NULL
&	NULL
0	NULL
``	NULL
2:70	NULL
Frac	NULL
1	NULL
I	NULL
U	NULL
to	NULL
|	NULL
__	NULL
ae	NULL
Frac	NULL
2	NULL
``	NULL
wo	NULL
|__	NULL
soo	NULL
Frac	NULL
3	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

MEL	NULL
cell	NULL
cyele	NULL
analysis	NULL
.	NULL

a	NULL
,	NULL
FACS	NULL
analysis	NULL
of	NULL
propidium	NULL
iodode-stained	NULL
log	NULL
phase	NULL
MEL	NULL
cells	NULL
(	NULL
top	NULL
)	NULL
and	NULL
elu-	NULL
e	NULL
triated	NULL
fractions	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Ex-	NULL
95	NULL
perimental	NULL
Procedures	NULL
.	NULL
``	NULL

Cells	NULL
containing	NULL
y	NULL
2n	NULL
amounts	NULL
of	NULL
DNA	NULL
were	NULL
defined	NULL
as	NULL
G	NULL
;	NULL
°	NULL
e	NULL
*C	NULL
phase	NULL
cells	NULL
,	NULL
those	NULL
with	NULL
2-47	NULL
amounts	NULL
as	NULL
S	NULL
Frac	NULL
4	NULL
phase	NULL
cells	NULL
,	NULL
and	NULL
those	NULL
with	NULL
47	NULL
as	NULL
G	NULL
,	NULL
and	NULL
M	NULL
phase	NULL
cells	NULL
.	NULL

b	NULL
,	NULL
cell	NULL
cycle	NULL
analysis	NULL
of	NULL
elutriated	NULL
MEL	NULL
cell	NULL
fractions	NULL
.	NULL

Using	NULL
data	NULL
from	NULL
a	NULL
Becton-Dickinson	NULL
FACScan	NULL
analysis	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
from	NULL
each	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
was	NULL
determined	NULL
for	NULL
0	NULL
o	NULL
-=-	NULL
so	NULL
=-each	NULL
fraction	NULL
.	NULL

Frac	NULL
5	NULL
Fraction	NULL
Number	NULL
o	NULL
00	NULL
goo	NULL
0	NULL
=	NULL
mo	NULL
00	NULL
Frac	NULL
6	NULL
o	NULL
==	NULL
io	NULL
___	NULL
ao	NULL
Frac	NULL
7	NULL
o	NULL
00	NULL
wo	NULL
000	NULL
ao	NULL
0	NULL
tion	NULL
of	NULL
nuclear	NULL
protein	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
although	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
increases	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
through	NULL
to	NULL
S	NULL
phase	NULL
,	NULL
it	NULL
contrasts	NULL
with	NULL
the	NULL
other	NULL
two	NULL
transcription	NULL
factors	NULL
by	NULL
exhibiting	NULL
a	NULL
sharp	NULL
decrease	NULL
in	NULL
activity	NULL
in	NULL
late	NULL
S/G	NULL
»	NULL
.	NULL

GATA-1	NULL
revealed	NULL
a	NULL
similar	NULL
profile	NULL
when	NULL
we	NULL
took	NULL
into	NULL
account	NULL
the	NULL
doubling	NULL
in	NULL
nuclear	NULL
chromatin	NULL
protein	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Fig	NULL
.	NULL

26	NULL
is	NULL
a	NULL
plot	NULL
of	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

20	NULL
showing	NULL
the	NULL
change	NULL
in	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
GATA-1	NULL
,	NULL
Oct-1	NULL
,	NULL
and	NULL
Spl	NULL
for	NULL
equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
all	NULL
three	NULL
factors	NULL
increase	NULL
between	NULL
G	NULL
,	NULL
and	NULL
early	NULL
S.	NULL
However	NULL
,	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
decreases	NULL
in	NULL
G	NULL
;	NULL
/M	NULL
(	NULL
to	NULL
9	NULL
%	NULL
of	NULL
peak	NULL
value	NULL
)	NULL
,	NULL
while	NULL
Octl	NULL
and	NULL
Spl	NULL
remain	NULL
high	NULL
in	NULL
Gy/M	NULL
(	NULL
93	NULL
and	NULL
147	NULL
%	NULL
of	NULL
peak	NULL
values	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

We	NULL
next	NULL
asked	NULL
whether	NULL
the	NULL
S	NULL
phase	NULL
peak	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
reflected	NULL
a	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
or	NULL
whether	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
being	NULL
regulated	NULL
by	NULL
some	NULL
post-translational	NULL
mech-anism	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
.	NULL

Nuclear	NULL
protein	NULL
from	NULL
equal	NULL
numbers	NULL
of	NULL
cell	NULL
cycle-fractionated	NULL
cells	NULL
was	NULL
separated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
Western	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
GATA-1	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

Variation	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
can	NULL
be	NULL
seen	NULL
(	NULL
lanes	NULL
1-7	NULL
)	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
in	NULL
mid-S8	NULL
phase	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
in	NULL
the	NULL
same	NULL
fraction	NULL
where	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
at	NULL
its	NULL
highest	NULL
(	NULL
Fig	NULL
.	NULL

30	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
changes	NULL
in	NULL
GATA-1	NULL
protein	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
broadly	NULL
similar	NULL
.	NULL

Quantitation	NULL
of	NULL
band	NULL
intensities	NULL
indicates	NULL
that	NULL
between	NULL
early	NULL
G	NULL
,	NULL
and	NULL
mid-S5	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
increases	NULL
5-fold	NULL
while	NULL
DNA	NULL
binding	NULL
activity	NULL
increases	NULL
4-fold	NULL
.	NULL

Similarly	NULL
,	NULL
between	NULL
mid-S	NULL
and	NULL
G	NULL
;	NULL
,	NULL
/M	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
decreases	NULL
8-fold	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
11-fold	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
variation	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Decreases	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
G1	NULL
G1	NULL
G1/S	NULL
S	NULL
S	NULL
SG2	NULL
GZ/M	NULL
T	NULL
self	NULL
non-self	NULL
ame	NULL
die	NULL
n	NULL
Cp	NULL
-	NULL
@	NULL
<	NULL
GATA-1	NULL
hat-h	NULL
--	NULL
~	NULL
.4—0u1	NULL
l	NULL
<	NULL
==	NULL
Sp	NULL
1	NULL
1.25	NULL
-B-	NULL
-	NULL
GATA	NULL
!	NULL

Pe	NULL
=-G-+	NULL
Oct1	NULL
8	NULL
>	NULL
§	NULL
é	NULL
£	NULL
l	NULL
2	NULL
6	NULL
2	NULL
3	NULL
)	NULL
<	NULL
B	NULL
5	NULL
5	NULL
&	NULL
<	NULL
Z	NULL
[	NULL
ad	NULL
0.00	NULL
f	NULL
t	NULL
r	NULL
u	NULL
t	NULL
t	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
G1	NULL
G1	NULL
GS	NULL
S	NULL
S	NULL
S/G2	NULL
G2M	NULL
Fraction	NULL
Number	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
peaks	NULL
in	NULL
mid-S	NULL
phase	NULL
.	NULL

a	NULL
,	NULL
cell	NULL
cycle	NULL
analysis	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
protein	NULL
from	NULL
equal	NULL
numbers	NULL
of	NULL
elutriated	NULL
MEL	NULL
cells	NULL
was	NULL
analyzed	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
double-stranded	NULL
end-labeled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
strong	NULL
GATA-1	NULL
site	NULL
by	NULL
EMSA	NULL
followed	NULL
by	NULL
autoradiography	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
identity	NULL
of	NULL
GATA-1	NULL
was	NULL
confirmed	NULL
by	NULL
observing	NULL
the	NULL
effects	NULL
of	NULL
50-fold	NULL
excess	NULL
unlabeled	NULL
GATA-1	NULL
oligonucleotide	NULL
self-competition	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
versus	NULL
competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
mutated	NULL
in	NULL
the	NULL
GATA-1	NULL
binding	NULL
site	NULL
(	NULL
Zane	NULL
10	NULL
)	NULL
.	NULL

The	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
asynchronous	NULL
MEL	NULL
cells	NULL
was	NULL
also	NULL
tested	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

Oct1	NULL
(	NULL
middle	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
Lower	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
DNA	NULL
binding	NULL
activities	NULL
were	NULL
also	NULL
measured	NULL
,	NULL
and	NULL
binding	NULL
specificities	NULL
were	NULL
confirmed	NULL
by	NULL
self-competition	NULL
.	NULL

b	NULL
,	NULL
quantitation	NULL
of	NULL
transcription	NULL
factor	NULL
DNA	NULL
binding	NULL
activity	NULL
per	NULL
ug	NULL
of	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Band	NULL
intensities	NULL
in	NULL
the	NULL
above	NULL
EMSAs	NULL
were	NULL
quantitated	NULL
by	NULL
laser	NULL
densitometry	NULL
and	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
per	NULL
cell	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
;	NULL
they	NULL
are	NULL
expressed	NULL
here	NULL
as	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
peak	NULL
of	NULL
GATA-1	NULL
binding	NULL
.	NULL

GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
is	NULL
primarily	NULL
due	NULL
to	NULL
variations	NULL
in	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
and	NULL
that	NULL
post-translational	NULL
mechanisms	NULL
make	NULL
at	NULL
most	NULL
a	NULL
minor	NULL
contribution	NULL
to	NULL
the	NULL
change	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
varying	NULL
amounts	NULL
of	NULL
nuclear	NULL
GATA-1	NULL
protein	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
might	NULL
come	NULL
about	NULL
by	NULL
changes	NULL
in	NULL
protein	NULL
stability	NULL
,	NULL
subcellular	NULL
localization	NULL
,	NULL
or	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
assayed	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
both	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
and	NULL
found	NULL
similar	NULL
S	NULL
phase	NULL
peaks	NULL
with	NULL
low	NULL
2467	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
G1	NULL
G1	NULL
s	NULL
_	NULL
so	NULL
$	NULL
G2	NULL
GM	NULL
T	NULL
ww	NULL
<	NULL
<	NULL
=	NULL
GATA-1	NULL
Us	NULL
as	NULL
on	NULL
--	NULL
UU	NULL
«	NULL
t	NULL
``	NULL
ﬂan-GATA—l	NULL
Smmam	NULL
:	NULL
j	NULL
-	NULL
<	NULL
GATA-1	NULL
<	NULL
<	NULL
=	NULL
288	NULL
]	NULL
<	NULL
=	NULL
188	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
protein	NULL
and	NULL
mRNA	NULL
peak	NULL
in	NULL
mid-S	NULL
phase	NULL
.	NULL

a	NULL
,	NULL
EMSA	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
for	NULL
details	NULL
)	NULL
.	NULL

6	NULL
,	NULL
the	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
GATA-1	NULL
protein	NULL
peak	NULL
in	NULL
mid-S	NULL
phase	NULL
.	NULL

Nuclear	NULL
protein	NULL
from	NULL
elutriated	NULL
MEL	NULL
cells	NULL
was	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
GATA-1l-specific	NULL
antibody	NULL
(	NULL
lanes	NULL
1-7	NULL
)	NULL
.	NULL

Asynchronous	NULL
MEL	NULL
cells	NULL
were	NULL
run	NULL
alongside	NULL
the	NULL
cell	NULL
cycle-fractionated	NULL
samples	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

c	NULL
,	NULL
the	NULL
steady	NULL
state	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
peaks	NULL
in	NULL
mid-S	NULL
phase	NULL
.	NULL

Total	NULL
RNA	NULL
extracted	NULL
from	NULL
elutriated	NULL
MEL	NULL
cells	NULL
was	NULL
size	NULL
fractionated	NULL
,	NULL
Northern	NULL
blotted	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
GATA-1-specific	NULL
DNA	NULL
fragment	NULL
(	NULL
upper	NULL
panel	NULL
,	NULL
lanes	NULL
1-7	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
asynchronous	NULL
cells	NULL
was	NULL
included	NULL
as	NULL
a	NULL
control	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

The	NULL
stained	NULL
agarose	NULL
gel	NULL
is	NULL
included	NULL
as	NULL
a	NULL
loading	NULL
control	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

levels	NULL
in	NULL
G	NULL
,	NULL
and	NULL
Gy/M	NULL
.	NULL

*	NULL
In	NULL
particular	NULL
,	NULL
we	NULL
do	NULL
not	NULL
detect	NULL
high	NULL
levels	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
G	NULL
,	NULL
/M	NULL
,	NULL
which	NULL
would	NULL
be	NULL
expected	NULL
if	NULL
the	NULL
drop	NULL
in	NULL
nuclear	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
we	NULL
observe	NULL
in	NULL
this	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
was	NULL
due	NULL
to	NULL
shuttling	NULL
between	NULL
compartments	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
variation	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
protein	NULL
was	NULL
due	NULL
to	NULL
changing	NULL
levels	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cell	NULL
cycle-fractionated	NULL
cells	NULL
,	NULL
separated	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
Northern	NULL
blotted	NULL
,	NULL
and	NULL
then	NULL
probed	NULL
for	NULL
GATA-1	NULL
message	NULL
(	NULL
Fig	NULL
.	NULL

3¢c	NULL
)	NULL
.	NULL

A	NULL
peak	NULL
in	NULL
the	NULL
level	NULL
of	NULL
steady	NULL
state	NULL
GATA-1	NULL
mRNA	NULL
was	NULL
seen	NULL
in	NULL
mid-S	NULL
phase	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
as	NULL
found	NULL
for	NULL
both	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
GATA-1	NULL
total	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
a	NULL
and	NULL
b	NULL
,	NULL
lanes	NULL
5	NULL
)	NULL
.	NULL

The	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
(	NULL
6-fold	NULL
)	NULL
between	NULL
early	NULL
G	NULL
;	NULL
and	NULL
mid-S	NULL
phase	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
protein	NULL
(	NULL
5-fold	NULL
)	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
4-fold	NULL
)	NULL
.	NULL

The	NULL
drop	NULL
in	NULL
the	NULL
level	NULL
of	NULL
message	NULL
between	NULL
mid-S	NULL
and	NULL
G	NULL
,	NULL
/M	NULL
decreases	NULL
only	NULL
a	NULL
little	NULL
less	NULL
(	NULL
4-fold	NULL
)	NULL
than	NULL
protein	NULL
and	NULL
mean	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
8-	NULL
and	NULL
7-fold	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
primary	NULL
control	NULL
over	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
at	NULL
the	NULL
RNA	NULL
level	NULL
,	NULL
but	NULL
there	NULL
may	NULL
be	NULL
some	NULL
additional	NULL
control	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
.	NULL

Variations	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
have	NULL
been	NULL
found	NULL
for	NULL
ubiquitous	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
some	NULL
of	NULL
the	NULL
central	NULL
events	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
including	NULL
Jun	NULL
(	NULL
35	NULL
)	NULL
,	NULL
E2F	NULL
(	NULL
36	NULL
)	NULL
,	NULL
factors	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
DNA	NULL
synthesis	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
,	NULL
and	NULL
S	NULL
phase-specific	NULL
histone	NULL
gene	NULL
expression	NULL
(	NULL
19	NULL
,	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
these	NULL
exam-ples	NULL
,	NULL
we	NULL
have	NULL
now	NULL
shown	NULL
that	NULL
GATA-1	NULL
,	NULL
a	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
targets	NULL
tissue-specific	NULL
genes	NULL
,	NULL
possesses	NULL
S	NULL
phase-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
cycling	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
GATA-1	NULL
expression	NULL
has	NULL
also	NULL
been	NULL
seen	NULL
in	NULL
quiescent	NULL
hematopoietic	NULL
progenitors	NULL
upon	NULL
entrance	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
38	NULL
)	NULL
.	NULL

2	NULL
M.	NULL
E.	NULL
Cullen	NULL
and	NULL
R.	NULL
K.	NULL
Patient	NULL
,	NULL
unpublished	NULL
observation	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
2468	NULL
C1	NULL
-	NULL
GaTasie	NULL
<	NULL
4	NULL
cami	NULL
~-	NULL
DNA	NULL
.	NULL

Nucleosomes	NULL
Replication	NULL
Machinery	NULL
4	NULL
NDHACO	NULL
)	NULL
8000	NULL
OQ	NULL
©	NULL
@	NULL
H	NULL
OQ	NULL
EARLY	NULL
S	NULL
-	NULL
high	NULL
[	NULL
GATA-1	NULL
]	NULL
-	NULL
replication	NULL
of	NULL
poised	NULL
erythroid	NULL
genes	NULL
C866	NULL
LATES	NULL
-	NULL
low	NULL
[	NULL
GATA-1	NULL
]	NULL
-	NULL
replication	NULL
of	NULL
non-erythroid	NULL
genes	NULL
(	NULL
with	NULL
GATA	NULL
sites	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Model	NULL
for	NULL
activation	NULL
of	NULL
GATA-l-responsive	NULL
genes	NULL
.	NULL

Left	NULL
side	NULL
,	NULL
the	NULL
availability	NULL
of	NULL
excess	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
when	NULL
GATA-1	NULL
target	NULL
genes	NULL
are	NULL
replicated	NULL
allows	NULL
GATA-1	NULL
to	NULL
compete	NULL
successfully	NULL
with	NULL
repressive	NULL
chromatin	NULL
(	NULL
gray	NULL
circles	NULL
)	NULL
.	NULL

Right	NULL
side	NULL
,	NULL
the	NULL
decrease	NULL
in	NULL
available	NULL
GATA-1	NULL
prevents	NULL
the	NULL
activation	NULL
of	NULL
non-erythroid	NULL
genes	NULL
responsive	NULL
to	NULL
other	NULL
GATA	NULL
family	NULL
members	NULL
.	NULL

There	NULL
are	NULL
several	NULL
ways	NULL
in	NULL
which	NULL
our	NULL
observations	NULL
can	NULL
be	NULL
interpreted	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
GATA-1-directed	NULL
control	NULL
of	NULL
the	NULL
erythroid	NULL
program	NULL
operates	NULL
through	NULL
the	NULL
regulation	NULL
of	NULL
erythroid-specific	NULL
replication	NULL
origins	NULL
containing	NULL
GATA	NULL
sites	NULL
,	NULL
causing	NULL
early	NULL
replication	NULL
and	NULL
hence	NULL
gene	NULL
activation	NULL
.	NULL

Since	NULL
several	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
as	NULL
origin-specific	NULL
replication	NULL
factors	NULL
by	NULL
certain	NULL
viruses	NULL
,	NULL
including	NULL
Oct1	NULL
and	NULL
BCCAAT/	NULL
NFL	NULL
family	NULL
members	NULL
(	NULL
39	NULL
)	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
specific	NULL
replication	NULL
origins	NULL
located	NULL
near	NULL
to	NULL
GATA-1-responsive	NULL
genes	NULL
may	NULL
be	NULL
activated	NULL
by	NULL
GATA-1	NULL
early	NULL
in	NULL
S	NULL
phase	NULL
,	NULL
inducing	NULL
early	NULL
replication	NULL
and	NULL
subsequent	NULL
transcriptional	NULL
activation	NULL
by	NULL
GATA-1	NULL
.	NULL

An	NULL
origin	NULL
of	NULL
replication	NULL
has	NULL
been	NULL
mapped	NULL
between	NULL
the	NULL
8	NULL
and	NULL
$	NULL
globin	NULL
genes	NULL
of	NULL
the	NULL
human	NULL
$	NULL
globin	NULL
locus	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
the	NULL
origin	NULL
used	NULL
for	NULL
early	NULL
replication	NULL
of	NULL
this	NULL
region	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
is	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
,	NULL
which	NULL
contains	NULL
several	NULL
GATA-1	NULL
sites	NULL
and	NULL
directs	NULL
B	NULL
globin	NULL
gene	NULL
expression	NULL
,	NULL
for	NULL
early	NULL
replication	NULL
of	NULL
this	NULL
region	NULL
of	NULL
the	NULL
chromosome	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
is	NULL
little	NULL
evidence	NULL
supporting	NULL
a	NULL
role	NULL
for	NULL
GATA-1	NULL
in	NULL
eukaryotic	NULL
origin	NULL
activity	NULL
or	NULL
replica-tion	NULL
,	NULL
although	NULL
it	NULL
does	NULL
appear	NULL
to	NULL
cause	NULL
growth	NULL
inhibition	NULL
and	NULL
bind	NULL
to	NULL
the	NULL
origin	NULL
of	NULL
replication	NULL
in	NULL
Escherichia	NULL
coli	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
from	NULL
our	NULL
data	NULL
the	NULL
peak	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

20	NULL
)	NULL
occurs	NULL
too	NULL
late	NULL
to	NULL
fire	NULL
the	NULL
$	NULL
globin	NULL
locus	NULL
origin	NULL
early	NULL
in	NULL
S	NULL
phase	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
more	NULL
attractive	NULL
model	NULL
based	NULL
on	NULL
the	NULL
correlation	NULL
between	NULL
replication	NULL
timing	NULL
of	NULL
genes	NULL
and	NULL
their	NULL
expression	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
10	NULL
)	NULL
positions	NULL
the	NULL
effect	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
downstream	NULL
of	NULL
replication	NULL
.	NULL

We	NULL
envisage	NULL
that	NULL
the	NULL
observed	NULL
pattern	NULL
of	NULL
GATA-1	NULL
binding	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
amplify	NULL
the	NULL
effect	NULL
of	NULL
early	NULL
replication	NULL
on	NULL
transcriptional	NULL
activation	NULL
.	NULL

As	NULL
early	NULL
replicating	NULL
erythroid	NULL
genes	NULL
become	NULL
stripped	NULL
of	NULL
chromatin	NULL
and	NULL
active	NULL
gene	NULL
complexes	NULL
,	NULL
GATA-1	NULL
binding	NULL
sites	NULL
in	NULL
regulatory	NULL
elements	NULL
,	NULL
including	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
,	NULL
become	NULL
available	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
left	NULL
side	NULL
)	NULL
.	NULL

By	NULL
having	NULL
sufficiently	NULL
high	NULL
levels	NULL
of	NULL
GATA-1	NULL
to	NULL
compete	NULL
successfully	NULL
with	NULL
the	NULL
reassembly	NULL
of	NULL
repressive	NULL
chromatin	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
GATA-l-activated	NULL
erythroid	NULL
genes	NULL
is	NULL
maintained	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
replication	NULL
of	NULL
the	NULL
locus	NULL
control	NULL
region	NULL
,	NULL
the	NULL
major	NULL
determinant	NULL
of	NULL
erythroid	NULL
expression	NULL
in	NULL
MEL	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
19	NULL
)	NULL
,	NULL
correlates	NULL
well	NULL
with	NULL
the	NULL
peak	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
GATA-1	NULL
throughout	NULL
S	NULL
phase	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
later	NULL
replicating	NULL
genes	NULL
that	NULL
are	NULL
not	NULL
part	NULL
of	NULL
the	NULL
erythroid	NULL
program	NULL
but	NULL
are	NULL
normally	NULL
responsive	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
GATA	NULL
family	NULL
.	NULL

Genes	NULL
containing	NULL
GATA	NULL
sites	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
non-erythroid	NULL
tissues	NULL
(	NULL
22	NULL
,	NULL
42-44	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
GATA-1	NULL
found	NULL
in	NULL
MEL	NULL
cells	NULL
,	NULL
it	NULL
seems	NULL
unlikely	NULL
that	NULL
passive	NULL
titration	NULL
of	NULL
GATA-1	NULL
by	NULL
binding	NULL
sites	NULL
in	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Decreases	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
early	NULL
replicating	NULL
activated	NULL
genes	NULL
is	NULL
sufficient	NULL
to	NULL
prevent	NULL
the	NULL
activation	NULL
of	NULL
later	NULL
replicating	NULL
genes	NULL
,	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
for	NULL
the	NULL
differential	NULL
effect	NULL
of	NULL
transcription	NULL
factor	NULL
IIIA	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
somatic	NULL
and	NULL
oocyte	NULL
5	NULL
S	NULL
RNA	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
decrease	NULL
in	NULL
GATA-1	NULL
activity	NULL
that	NULL
occurs	NULL
during	NULL
late	NULL
S	NULL
phase	NULL
is	NULL
required	NULL
to	NULL
prevent	NULL
activation	NULL
of	NULL
non-erythroid	NULL
genes	NULL
subject	NULL
to	NULL
activation	NULL
by	NULL
other	NULL
GATA	NULL
family	NULL
members	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
right	NULL
side	NULL
)	NULL
.	NULL

By	NULL
ensuring	NULL
that	NULL
GATA	NULL
factor	NULL
availability	NULL
and	NULL
target	NULL
site	NULL
accessibility	NULL
occur	NULL
in	NULL
the	NULL
same	NULL
temporal	NULL
compartment	NULL
of	NULL
S	NULL
phase	NULL
,	NULL
subsets	NULL
of	NULL
genes	NULL
with	NULL
closely	NULL
related	NULL
control	NULL
sequences	NULL
can	NULL
be	NULL
activated	NULL
independently	NULL
.	NULL

Finally	NULL
,	NULL
another	NULL
interpretation	NULL
of	NULL
these	NULL
data	NULL
has	NULL
been	NULL
prompted	NULL
by	NULL
several	NULL
recent	NULL
papers	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
GATA-1	NULL
in	NULL
control	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
GATA-1	NULL
in	NULL
both	NULL
hematopoietic	NULL
and	NULL
non-hematopoietic	NULL
cell	NULL
lines	NULL
can	NULL
lead	NULL
to	NULL
alterations	NULL
in	NULL
the	NULL
length	NULL
of	NULL
segments	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
ectopic	NULL
GATA-1	NULL
cause	NULL
S	NULL
phase	NULL
to	NULL
lengthen	NULL
in	NULL
NIH3T3	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
reduction	NULL
in	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
we	NULL
see	NULL
here	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
correctly	NULL
timed	NULL
exit	NULL
from	NULL
S	NULL
phase	NULL
.	NULL

GATA-1	NULL
also	NULL
appears	NULL
to	NULL
function	NULL
as	NULL
an	NULL
erythroid	NULL
survival	NULL
factor	NULL
,	NULL
since	NULL
differentiation	NULL
of	NULL
GATA-1	NULL
negative	NULL
ES	NULL
cells	NULL
along	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
or	NULL
abrogation	NULL
of	NULL
GATA-1	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
,	NULL
leads	NULL
to	NULL
premature	NULL
apoptosis	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
high	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
we	NULL
see	NULL
in	NULL
S	NULL
phase	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
prevent	NULL
apoptosis	NULL
.	NULL

The	NULL
emerging	NULL
picture	NULL
is	NULL
that	NULL
the	NULL
choice	NULL
among	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
apoptosis	NULL
is	NULL
affected	NULL
by	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
.	NULL

Our	NULL
data	NULL
demonstrating	NULL
a	NULL
peak	NULL
of	NULL
GATA-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
mid-8	NULL
,	NULL
downstream	NULL
of	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
cell	NULL
cycle	NULL
checkpoints	NULL
,	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
GATA-1	NULL
has	NULL
a	NULL
cell	NULL
cycle	NULL
role	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Geoff	NULL
Partington	NULL
for	NULL
assistance	NULL
with	NULL
some	NULL
of	NULL
the	NULL
early	NULL
EMSA	NULL
experiments	NULL
,	NULL
Doug	NULL
Engel	NULL
for	NULL
anti-GATA-1	NULL
antibody	NULL
,	NULL
Rob	NULL
Nicolas	NULL
for	NULL
oligonucleotides	NULL
,	NULL
John	NULL
Pizzey	NULL
for	NULL
assistance	NULL
with	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
ICRF	NULL
FACS	NULL
lab	NULL
for	NULL
help	NULL
with	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
Tariq	NULL
Enver	NULL
and	NULL
Louis	NULL
Mahadevan	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
.	NULL

Till	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
McCulloch	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Siminovitch	NULL
,	NULL
L.	NULL
(	NULL
1964	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

51	NULL
,	NULL
29-36	NULL
.	NULL

Svaren	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Chalkley	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

6	NULL
,	NULL
52-56	NULL
.	NULL

Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
217-227	NULL
.	NULL

Brown	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
359-365	NULL
.	NULL

Villarreal	NULL
,	NULL
L.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

55	NULL
,	NULL
512-542	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Brewer	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Patient	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
1301-1308	NULL
.	NULL

Wilson	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Patient	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
4296-4804	NULL
.	NULL

Proudfoot	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Monks	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

4	NULL
,	NULL
369-381	NULL
.	NULL

Williams	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Lee	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
Proudfoot	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24	NULL
,	NULL
549-557	NULL
10	NULL
.	NULL

Holmquist	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Am	NULL
.	NULL

J	NULL
.	NULL

Human	NULL
Genet	NULL
.	NULL

40	NULL
,	NULL
151-173	NULL
11	NULL
.	NULL

Calza	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Eckhardt	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
DelGiudice	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Schildkraut	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
36	NULL
,	NULL
689-696	NULL
12	NULL
.	NULL

Brown	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Iqbal	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Stuart	NULL
,	NULL
S.	NULL
,	NULL
Hatton	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Valinsky	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Schildkraut	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
450-457	NULL
13	NULL
.	NULL

Hatton	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Dhar	NULL
,	NULL
V.	NULL
,	NULL
Brown	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Iqbal	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Stuart	NULL
,	NULL
S.	NULL
,	NULL
Didamo	NULL
,	NULL
V.	NULL
T.	NULL
,	NULL
and	NULL
Schildkraut	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
2149-2158	NULL
14	NULL
.	NULL

Epner	NULL
,	NULL
E.	NULL
,	NULL
Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8081-8085	NULL
15	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Epner	NULL
,	NULL
E.	NULL
,	NULL
Driscoll	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Enver	NULL
,	NULL
T.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1637-1649	NULL
16	NULL
.	NULL

Wolffe	NULL
,	NULL
A.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

99	NULL
,	NULL
201-206	NULL
17	NULL
.	NULL

Gottesfeld	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Bloomer	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1982	NULL
)	NULL
Cell	NULL
28	NULL
,	NULL
781-791	NULL
18	NULL
.	NULL

Wormington	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Schlissel	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1982	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

47	NULL
,	NULL
879-884	NULL
19	NULL
.	NULL

Dhar	NULL
,	NULL
V.	NULL
,	NULL
Mager	NULL
,	NULL
D.	NULL
,	NULL
Iqbal	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Schildkraut	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
4958-4965	NULL
20	NULL
.	NULL

Pevay	NULL
,	NULL
L.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Robertson	NULL
,	NULL
E.	NULL
,	NULL
Klein	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Dagati	NULL
,	NULL
V.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Costantini	NULL
,	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
849	NULL
,	NULL
257-260	NULL
21	NULL
.	NULL

Simon	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Pevny	NULL
,	NULL
L.	NULL
,	NULL
Wiles	NULL
,	NULL
M.	NULL
V.	NULL
,	NULL
Keller	NULL
,	NULL
G.	NULL
,	NULL
Costantini	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Nat	NULL
.	NULL

Genet	NULL
.	NULL

1	NULL
,	NULL
92-98	NULL
22	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
575-581	NULL
28	NULL
.	NULL

Leonard	NULL
,	NULL
M.	NULL
,	NULL
Brice	NULL
,	NULL
M.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
a	NULL
1071-1079	NULL
24	NULL
.	NULL

Dubart	NULL
,	NULL
A.	NULL
,	NULL
Romeo	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Dumenil	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
3711-3721	NULL
25	NULL
.	NULL

Weiss	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
9623-9627	NULL
26	NULL
.	NULL

Blobel	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1687-1694	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

82	NULL
.	NULL

38	NULL
.	NULL

84	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

GATA-1	NULL
DNA	NULL
Binding	NULL
Decreases	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
Friend	NULL
,	NULL
C.	NULL
,	NULL
Scher	NULL
,	NULL
W.	NULL
,	NULL
Holland	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sato	NULL
,	NULL
T.	NULL
(	NULL
1971	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
68	NULL
,	NULL
378-382	NULL
Tate	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Wilder	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Cram	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
Wharton	NULL
,	NULL
W.	NULL
(	NULL
1983	NULL
)	NULL
Cytometry	NULL
4	NULL
,	NULL
211-215	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Nicolas	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Plumb	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Goodwin	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
1299-1314	NULL
Lobanenkov	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Nicolas	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Adler	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Paterson	NULL
,	NULL
H.	NULL
,	NULL
Klenova	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Polotskaja	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
and	NULL
Goodwin	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Oncogene	NULL
5	NULL
,	NULL
1748-1753	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Segil	NULL
,	NULL
N.	NULL
,	NULL
Roberts	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
Heintz	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

56	NULL
,	NULL
285-292	NULL
Dalton	NULL
,	NULL
S.	NULL
,	NULL
Coleman	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Wells	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
601-606	NULL
Dou	NULL
,	NULL
Q.	NULL
P.	NULL
,	NULL
Fridovich-Keil	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Pardee	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
1157-1161	NULL
Carter	NULL
,	NULL
R.	NULL
,	NULL
Cosenza	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Pena	NULL
,	NULL
A.	NULL
,	NULL
Lipson	NULL
,	NULL
K.	NULL
,	NULL
Soprano	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Soprano	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
229-235	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
258	NULL
,	NULL
424-429	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39.	NULL
.	NULL

Kitsberg	NULL
,	NULL
D.	NULL
,	NULL
Selig	NULL
,	NULL
S.	NULL
,	NULL
Keshet	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Cedar	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
866	NULL
,	NULL
588-590	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

2469	NULL
Holthuis	NULL
,	NULL
J.	NULL
,	NULL
Owen	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
van	NULL
Wijnen	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Wright	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Ramsey-Ewing	NULL
,	NULL
A.	NULL
,	NULL
Kennedy	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Carter	NULL
,	NULL
R.	NULL
,	NULL
Cosenza	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Soprano	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Lian	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Stein	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
1454-1457	NULL
Sposi	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Zon	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Care	NULL
,	NULL
A.	NULL
,	NULL
Valtieri	NULL
,	NULL
M.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Gabbianelli	NULL
,	NULL
M.	NULL
,	NULL
Mariani	NULL
,	NULL
G.	NULL
,	NULL
Bottero	NULL
,	NULL
L.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Peschle	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.8.A	NULL
.	NULL

89	NULL
,	NULL
6353-6357	NULL
DePamphilis	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
635-638	NULL
Trudel	NULL
,	NULL
P.	NULL
,	NULL
Provost	NULL
,	NULL
S.	NULL
,	NULL
Massie	NULL
,	NULL
B.	NULL
,	NULL
Chartrand	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Wall	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
BioTech-niques	NULL
20	NULL
,	NULL
684-698	NULL
Neave	NULL
,	NULL
B.	NULL
,	NULL
Rodaway	NULL
,	NULL
A.	NULL
,	NULL
Wilson	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Patient	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Holder	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mechanisms	NULL
Dev	NULL
.	NULL

51	NULL
,	NULL
169-182	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1650-1662	NULL
Laverriere	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
MacNeill	NULL
,	NULL
C.	NULL
,	NULL
Mueller	NULL
,	NULL
C.	NULL
,	NULL
Poelmann	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Burch	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
E.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
28177-23184	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
GATA-1	NULL
DNA	NULL
Binding	NULL
Activity	NULL
Is	NULL
Down-regulated	NULL
in	NULL
Late	NULL
S	NULL
Phase	NULL
in	NULL
Erythroid	NULL
Cells	NULL
Martin	NULL
E.	NULL
Cullen	NULL
and	NULL
Roger	NULL
K.	NULL
Patient	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:2464-2469.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.4.2464	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/4/2464	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
44	NULL
references	NULL
,	NULL
23	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
full.html	NULL
#	NULL
ref-list-	NULL
1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

